The Dutch Cancer Society (KWF) has awarded 8 grants to Radboudumc researchers. We congratulate them with this funding and wish them success with their great work.
Research project: Focus on values to stimulate shared decisions in patients with thyroid cancer: A multifaceted COMmunication BOoster (COMBO).
Peep Stalmeier, theme Womens's cancers, RIHS
Approved budget: € 508,428
Research project: Phase IIa study of ex vivo-generated allogeneic NK cell infusion in combination with subcutaneous IL-15 superagonist ALT-803 in relapsed/refractory AML patients.
Harry Dolstra, theme Cancer development and immune defense, RIMLS
Approved budget: € 1,294,415
Research project: Galactin-9 is required for Dendritic Cell function during anti-melanoma immunity.
Annemiek van Spriel, theme Cancer development and immune defense, RIMLS
Approved budget: € 623,515
Research project: FORwards: Feasibility and effectiveness Of Real-world use of the SWORD evidence-based
psychological intervention for fear of cancer recurrence.
Judith Prins, theme Women's cancers, RIHS
Approved budget: € 453,919
Young Investigator grant:
Research project: Understanding brain mechanisms of cancer-related fatigue: a sickness-behaviour approach.
Marieke van der Schaaf, theme Stress related disorders, DCMN
Approved budget: € 632,612
Unique high risk project:
Research project: The cell by cell measuring of the response to therapy to detect resistant cells.
Klaas Mulder, theme Cancer development and immune defense, RIMLS
Approved budget: € 220,646
Research project: STOPOVCA: STOP OVarian CAncer: the implementation of opportunistic salpingectomy to prevent ovarian cancer.
Joanne de Hullu, theme Women's cancers, RIHS
Approved budget: € 416,684
Research project: ImplemenTation of concentration gUided dosing to optimize treatmeNt outcomE in patients treated with oral targeted anticancer drugs (TUNE project).
Ingrid Desar, theme Rare cancers, RIHS
Approved budget: € 683,113
Go to the Dutch Cancer Society website (KWF).
Related news items
Hans van Bokhoven newly elected in Academia Europaea22 August 2019
The Academia Europaea is a functioning European Academy of Humanities, Letters and Sciences, composed of individual members.read more
Drug-induced interstitial lung disease in advanced breast cancer patients receiving everolimus22 August 2019
In Targeted Oncology, Annelieke Willemsen, Carla van Herpen and colleagues, showed that pulmonary function test with diffusion capacity of the lungs for carbon monoxide and serum biomarkers can be of aid to differentiate everolimus-related interstitial lung disease from other respiratory problems.read more
Publication in PNAS on dissecting EEC syndrome using single-cell RNA-seq22 August 2019
PhD candidates Eduardo Soares and Quan Xu in Jo Huiqing Zhou’s group in Molecular Developmental Biology, theme Reconstruction and regenerative medicine, have published a paper in PNAS on the disease mechanism of EEC syndrome using single-cell RNA-seq technology and patient-derived iPSCs.read more
Patient trust and participation in cell biological research21 August 2019
Alessandra Cambi and Gert Olthuis, discuss key ethical issues inherent in the development and the value of building trust and trustworthiness.read more
NWO grant for a tissue-generating patch to close diaphragmatic defects21 August 2019
Willeke Daamen and Toin van Kuppevelt, theme Reconstructive and regenerative medicine, were recently awarded a 690 k€ grant by NWO, domain Applied & Engineering Sciences, for the development of advanced patches for closure of diaphragmatic defects in children with congenital diaphragmatic hernia.read more
Front cover Human Mutation21 August 2019
The MetaDome web server build to interpret genetic variants based on genetic tolerance and homologous protein domains is featured on the Cover of Human Mutation. MetaDome was developed by Laurens van de Wiel, Coos Baakman, Daan Gilissen, Joris Veltman, Gert Vriend and Christian Gilissen,read more